GLP-1 drugs are increasing thyroid nodule detectionFebruary 11, 2026About the speakersAdriana Ramirez, MD, MPH, FACSAssistant Professor of Surgery (Oncology, Endocrine)
Elevated peptide concentrations provide stronger inflammatory modulation, crucial for managing severe tissue damage and chronic inflammatory conditions
Genome Biol (2011) 12:233
The NHS and NICE provide comprehensive guidance on GLP-1 receptor agonist prescribing, though specific recommendations about time of day are limited, reflecting the flexibility inherent in most formulations
Clinical use typically falls in the 100300 mcg subcutaneous range, administered before sleep
Why GLP-1 Drug Lawsuits Are Being Filed as an MDL GLP-1 drug injury claims are particularly well-suited to an MDL structure because the injuries plaintiffs have suffered vary significantly from one individual to the next